CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 424B5 Offering Prospectus
- 4 Grant or award Director acquired 8,260 shares (grant or award)
- 4 Other acquisition Chief Scientific Officer acquired 2,000 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,573 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 6,994 shares (grant or award)
- 4 Other acquisition President and CEO acquired 3,000 shares (other)
- 4 Open-market buy Chief Financial Officer bought 94,500 shares at an average $1.22 ($114,968)
- 4 Open-market buy Director bought 100,000 shares at $1.06 ($105,530)
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 2,400 shares (other)
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
Page 16 of 29 · 576 filings